Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$4.33 - $5.75 $44,144 - $58,621
-10,195 Reduced 44.08%
12,933 $67,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $66,839 - $123,503
23,128 New
23,128 $121,000
Q1 2023

May 15, 2023

SELL
$1.07 - $2.95 $41,753 - $115,114
-39,022 Reduced 78.42%
10,739 $11,000
Q4 2022

Feb 14, 2023

BUY
$1.81 - $8.14 $90,067 - $405,054
49,761 New
49,761 $129,000
Q2 2022

Aug 15, 2022

SELL
$6.82 - $13.82 $77,454 - $156,953
-11,357 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.65 - $15.28 $33,936 - $44,510
-2,913 Reduced 20.41%
11,357 $160,000
Q4 2021

Feb 14, 2022

SELL
$12.37 - $16.77 $13,446 - $18,228
-1,087 Reduced 7.08%
14,270 $207,000
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $210,390 - $264,908
15,357 New
15,357 $217,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $619M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.